These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3737786)

  • 1. Serial dexamethasone suppression tests in psychiatric illness: Part II. A study in major depressive disorder.
    Baumgartner A; Gräf KJ; Kürten I
    Psychiatry Res; 1986 May; 18(1):25-43. PubMed ID: 3737786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial dexamethasone suppression tests in psychiatric illness: Part I. A study in schizophrenia and mania.
    Baumgartner A; Gräf KJ; Kürten I
    Psychiatry Res; 1986 May; 18(1):9-23. PubMed ID: 2874578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial dexamethasone suppression tests in psychiatric illness: Part III. The influence of intervening variables.
    Baumgartner A; Haack D; Vecsei P
    Psychiatry Res; 1986 May; 18(1):45-64. PubMed ID: 3737787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H; Sarai M
    Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.
    Greden JF; Gardner R; King D; Grunhaus L; Carroll BJ; Kronfol Z
    Arch Gen Psychiatry; 1983 May; 40(5):493-500. PubMed ID: 6340634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone suppression test in dementia: a review of the literature.
    Skare S; Pew B; Dysken M
    J Geriatr Psychiatry Neurol; 1990; 3(3):124-38. PubMed ID: 2282129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
    Guthrie SK; Vartanian L; Grunhaus L; Hariharan M; Pande A; Haskett RF
    Acta Psychiatr Scand; 1990 Dec; 82(6):427-32. PubMed ID: 2291411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objectifying psychiatric diagnosis and treatment with the dexamethasone suppression test.
    Pollock DC; Sheehan ME
    J Fam Pract; 1982 Oct; 15(4):641-5. PubMed ID: 6288832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DST as a predictor of outcome in depression: a meta-analysis.
    Ribeiro SC; Tandon R; Grunhaus L; Greden JF
    Am J Psychiatry; 1993 Nov; 150(11):1618-29. PubMed ID: 8214170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial dexamethasone tests for predicting relapse in depressive disorder.
    Targum SD
    South Med J; 1984 Nov; 77(11):1402-5. PubMed ID: 6494962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DST results in nonpsychotic depressed outpatients.
    Khan A; Johnson F; Avery DH; Cohen S; Scherzo B; Dunner DL
    Am J Psychiatry; 1988 Sep; 145(9):1153-6. PubMed ID: 3046385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
    Rybakowski J; Plocka M
    J Affect Disord; 1992 Feb; 24(2):87-91. PubMed ID: 1541770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone suppression test response in major depression: stability across hospitalizations.
    Coryell W; Schlesser MA
    Psychiatry Res; 1983 Mar; 8(3):179-89. PubMed ID: 6574537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of antidepressant based on the dexamethasone suppression test.
    Fraser AR
    Am J Psychiatry; 1983 Jun; 140(6):786-7. PubMed ID: 6846641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dexamethasone suppression test in psychiatry.
    Joyce PR; Brinded PJ; Sellman D; Donald RA; Elder PA
    N Z Med J; 1987 Mar; 100(820):173-5. PubMed ID: 3452036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated dexamethasone suppression test in major depression.
    Hellebuyck H; Maes M; Suy E
    Acta Psychiatr Belg; 1988; 88(5-6):378-86. PubMed ID: 3079168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review.
    Arana GW; Baldessarini RJ; Ornsteen M
    Arch Gen Psychiatry; 1985 Dec; 42(12):1193-204. PubMed ID: 3000317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.